日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia

将帕克替尼用于治疗MYD88突变型华氏巨球蛋白血症

Liu, Shirong; Kofides, Amanda; Liu, Xia; Hatcher, John M; Sun, Hao; Tsakmaklis, Nicholas; Guijosa, Alberto; Guerrera, Maria L; Pizzarella, Dominic; Peachey, Abigail L; Patterson, Christopher J; Hunter, Zachary R; Meid, Kirsten; Castillo, Jorge J; Sarosiek, Shayna R; Treon, Steven P

Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia

伊布替尼和维奈克拉作为有症状、初治华氏巨球蛋白血症的一线治疗

Castillo, Jorge J; Branagan, Andrew R; Sermer, David; Flynn, Catherine A; Meid, Kirsten; Little, Megan; Stockman, Katherine; White, Timothy; Canning, Alexa; Guerrera, Maria L; Kofides, Amanda; Liu, Shirong; Liu, Xia; Richardson, Kris; Tsakmaklis, Nicholas; Patterson, Christopher J; Hunter, Zachary R; Treon, Steven P; Sarosiek, Shayna

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

利用多组学方法鉴定MYD88突变型华氏巨球蛋白血症患者伊布替尼疗效的可靠预测因子

Richardson, Kris; Castillo, Jorge J; Sarosiek, Shayna R; Branagan, Andrew R; Flynn, Catherine A; Meid, Kirsten; Gustine, Joshua N; Liu, Xia; Kofides, Amanda; Liu, Shirong; Wolf, Julie L; Kacena, Katherine A; Patterson, Christopher J; Guerrera, Maria Luisa; Tsakmaklis, Nicholas; Treon, Steven P; Hunter, Zachary R

Venetoclax in Previously Treated Waldenström Macroglobulinemia

维奈托克用于既往接受过治疗的华氏巨球蛋白血症

Castillo, Jorge J; Allan, John N; Siddiqi, Tanya; Advani, Ranjana H; Meid, Kirsten; Leventoff, Carly; White, Timothy P; Flynn, Catherine A; Sarosiek, Shayna; Branagan, Andrew R; Demos, Maria G; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Xu, Lian; Yang, Guang; Patterson, Christopher J; Hunter, Zachary R; Davids, Matthew S; Furman, Richard R; Treon, Steven P

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

对初治华氏巨球蛋白血症患者进行伊布替尼单药治疗的长期随访

Castillo, Jorge J; Meid, Kirsten; Gustine, Joshua N; Leventoff, Carly; White, Timothy; Flynn, Catherine A; Sarosiek, Shayna; Demos, Maria G; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Xu, Lian; Yang, Guang; Branagan, Andrew R; O'Donnell, Elizabeth; Raje, Noopur; Yee, Andrew J; Patterson, Christopher J; Hunter, Zachary R; Treon, Steven P

Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy

对伊布替尼单药治疗产生耐药性后,Waldenström巨球蛋白血症的自然病程

Gustine, Joshua N; Sarosiek, Shayna; Flynn, Catherine A; Meid, Kirsten; Leventoff, Carly; White, Timothy; Guerrera, Maria Luisa; Xu, Lian; Kofides, Amanda; Tsakmaklis, Nicholas; Munshi, Manit; Demos, Maria; Patterson, Christopher J; Liu, Xia; Yang, Guang; Hunter, Zachary R; Branagan, Andrew R; Treon, Steven P; Castillo, Jorge J

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

SRC家族激酶HCK在MYD88突变淋巴瘤中作为SYK激活驱动因子的新作用

Munshi, Manit; Liu, Xia; Kofides, Amanda; Tsakmaklis, Nickolas; Guerrera, Maria Luisa; Hunter, Zachary R; Palomba, M Lia; Argyropoulos, Kimon V; Patterson, Christopher J; Canning, Alexa G; Meid, Kirsten; Gustine, Joshua; Branagan, Andrew R; Flynn, Catherine A; Sarosiek, Shayna; Castillo, Jorge J; Wang, Jinhua; Buhrlage, Sara J; Gray, Nathanael S; Munshi, Nikhil C; Anderson, Kenneth C; Treon, Steven P; Yang, Guang

Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia

伊布替尼联合CXCR4拮抗剂ulocuplumab治疗CXCR4突变型华氏巨球蛋白血症的I期研究

Treon, Steven P; Meid, Kirsten; Hunter, Zachary R; Flynn, Catherine A; Sarosiek, Shayna R; Leventoff, Carly R; White, Timothy P; Cao, Yang; Roccaro, Aldo M; Sacco, Antonio; Demos, Maria G; Guerrera, Maria Luisa; Kofides, Amanda; Liu, Xia; Xu, Lian; Patterson, Christopher J; Munshi, Manit; Tsakmaklis, Nicholas; Yang, Guang; Ghobrial, Irene M; Branagan, Andrew R; Castillo, Jorge J

The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance

HCK/BTK 抑制剂 KIN-8194 对 MYD88 驱动的淋巴瘤有效,并可克服突变的 BTKCys481 依鲁替尼耐药性

Guang Yang, Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides, Jiaji G Chen, Nicholas Tsakmaklis, Maria G Demos, Maria Luisa Guerrera, Lian Xu, Zachary R Hunter, Jinwei Che, Christopher J Patterson, Kirsten Meid, Jorge J Castillo, Nikhil C Munshi, Kenneth C Anderson, Michael Cameron, Sara J

Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88(L265P) in Waldenström Macroglobulinemia

诊断性二代测序经常无法检测到华氏巨球蛋白血症中的MYD88(L265P)突变

Kofides, Amanda; Hunter, Zachary R; Xu, Lian; Tsakmaklis, Nicholas; Demos, Maria G; Munshi, Manit; Liu, Xia; Guerrera, Maria Luisa; Leventoff, Carly R; White, Timothy P; Flynn, Catherine A; Meid, Kirsten; Patterson, Christopher J; Yang, Guang; Branagan, Andrew R; Sarosiek, Shayna; Castillo, Jorge J; Treon, Steven P; Gustine, Joshua N